Multiparametric Imaging for Analysis of MVNT (Multinodular and Vacuolating Neuronal Tumor)
- Conditions
- Benign Neuronal Desease
- Registration Number
- NCT04103190
- Lead Sponsor
- Fondation Ophtalmologique Adolphe de Rothschild
- Brief Summary
Differential diagnoses of MVNT include DNT (dysembryoplastic neuroepithelial tumor), low-grade gliomas, cortical dysplasias or even hamartomas.
- Detailed Description
Differential diagnoses of MVNT include DNT (dysembryoplastic neuroepithelial tumor), low-grade gliomas, cortical dysplasias or even hamartomas.
However, in order to avoid an invasive surgical procedure to remove the lesion, a certain diagnosis of its benignity is essential. The contribution of advanced techniques in MRI, such as spectroscopy in the characterization of these lesions, has not yet been studied today
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 50
- Patient over 18 years old
- Suspicion of MVNT on an MRI: it is considered that it will be necessary at least the 2 major criteria associated with at least 1 minor criterion to enter the definition of suspicion of MVNT:
Major criteria:
- Multinodular aspect in cluster
- High FLAIR hypersignal / T2
Minor criteria:
-
Absence of mass effect
-
Hyposignal T1
-
Center of the lesion in hypsignal FLAIR or T1 hypersignal
- Affiliate or beneficiary of a Social Security scheme
- Having received informed information about the study and consenting to participate in the study
- Patient benefiting from a legal protection measure
- Pregnant or lactating woman
- Contraindication to MRI
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Description of a new radiological entity on Spectroscopy : the MVNT (Multinodular and Vacuolating Neuronal Tumor) 1 day area under curve of the N-Acetylaspartate Spectroscopie
Description of a new radiological entity on Spectroscopy : : the MVNT (Multinodular and Vacuolating Neuronal Tumor) 1 day area under curve of choline Spectroscopie
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (7)
Fondation Adolphe de Rothschild
🇫🇷Paris, France
Groupe Hospitalier Pellegrin
🇫🇷Bordeaux, France
Hôpital Pierre Paul Riquet, CHU Purpan
🇫🇷Toulouse, France
CHU Rennes
🇫🇷Rennes, France
CHU de Rouen
🇫🇷Rouen, France
Hôpital Laennec
🇫🇷Saint-Herblain, France
Centre Hospitalier Lyon Sud
🇫🇷Pierre Bénite, France